NANOVIRICIDES, INC. (47) | Business Finance (32)

Browse by Subcategory

Recent Contracts

Underwriting Agreement with Kingswood Capital Markets, a Division of Benchmark Investments, Inc. dated July 8, 2020 (Filed With SEC on July 13, 2020)
Placement Agent Agreement, dated May 21, 2020 by and between among NanoViricides, Inc. Maxim Group LLC and Kingswood Capital Markets, a division of Benchmark Investments, Inc (Filed With SEC on May 22, 2020)
Form of Securities Purchase Agreement dated May 21, 2020 by and between NanoViricides, Inc. and certain purchasers (Filed With SEC on May 22, 2020)
Form of Common Stock Purchase Agreement (Filed With SEC on January 28, 2020)
Form of Exchange Agreement (Filed With SEC on January 28, 2020)
Form of Series A Conversion Waiver (Filed With SEC on January 8, 2020)
Open End Mortgage Note (Filed With SEC on December 19, 2019)
Form of Representatives Warrant (Filed With SEC on September 27, 2019)
Underwriting with Aegis Capital Corp. dated January 21, 2020 (Filed With SEC on January 27, 2020)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 8, 2020)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 8, 2020)
Form of Series A Conversion Waiver (Filed With SEC on January 7, 2020)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 7, 2020)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 7, 2020)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 23, 2019)
Form of Series A Conversion Waiver (Filed With SEC on December 23, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 23, 2019)
Deferred Expense Exchange Agreement (Filed With SEC on December 19, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 17, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 17, 2019)
Form of Series A Conversion Waiver (Filed With SEC on December 17, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on November 29, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on November 29, 2019)
Form of Series A Conversion Waiver (Filed With SEC on November 29, 2019)
Form of Series A Conversion Waiver (Filed With SEC on September 27, 2019)
Form of Common Stock Purchase Warrant (Filed With SEC on September 27, 2019)
Form of Pre-Funded Warrant (Filed With SEC on September 27, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on September 27, 2019)
Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on September 27, 2019)
Form of Underwriting Agreement (Filed With SEC on September 27, 2019)
Form of Common Stock Purchase Warrant (Filed With SEC on March 1, 2019)
Form of Securities Purchase Agreement dated February 27, 2019 by and between NanoViricides, Inc. and certain purchasers (Filed With SEC on March 1, 2019)